The story of Viagra offers a intricate case study for stakeholders eyeing pharma. While first sales were remarkable, present patent expiration and the rise of alternative versions have significantly impacted earnings. https://iwaniywh878749.bloggin-ads.com/64163829/the-blue-pill-and-pharma-a-risky-investment